(336 days)
Not Found
Not Found
No
The summary describes a standard ECG monitor and respiration pacer without mentioning any AI or ML capabilities.
No
The device is described as a monitor that measures heart rate and provides a respiration timer, used for studying heart rate variations. It does not provide any treatment or therapy.
No
The device measures heart rate and respiration for specific studies, but it is not explicitly stated that it diagnoses a disease or condition. Its purpose appears to be data collection for analysis of heart rate variations in response to respiration.
No
The description explicitly mentions a "measuring board," which is a hardware component used for acquiring ECG data. This indicates the device is not solely software.
Based on the provided information, the ANS2000 is not an IVD (In Vitro Diagnostic).
Here's why:
- IVDs are used to examine specimens derived from the human body. The intended use and device description clearly state that the ANS2000 is an ECG Monitor and Respiration Pacer that measures heart rate and provides a respiration timer. This involves measuring physiological signals directly from the patient's body (heart and respiration), not analyzing specimens like blood, urine, or tissue.
- The device operates externally to the body. It's a monitor and pacer, not something that interacts with or analyzes internal bodily fluids or tissues.
Therefore, the ANS2000 falls under the category of a medical device that measures physiological parameters, but it does not meet the definition of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
"The ANS2000 is an ECG Monitor and Respiration Pacer that measures heart rate and provides a respiration timer for the purpose of measuring heart rate variations in response to respiration. The measuring heart rate is used in studies of patients in which it is important to know the interval between heartbeats and also to have analysis with the patient's breathing."
Product codes
74 DPS
Device Description
Not Found
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Not Found
Key Metrics
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2340 Electrocardiograph.
(a)
Identification. An electrocardiograph is a device used to process the electrical signal transmitted through two or more electrocardiograph electrodes and to produce a visual display of the electrical signal produced by the heart.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird-like symbol with three lines representing its wings or feathers. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the symbol in a circular fashion. The logo is black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG 1 2 1998
Mr. D. Eugene Hokanson D.E. Hokanson, Incorporated 12840 Northeast 21st Place Bellevue, WA 98005
Re: K973426 ANS2000 ECG Monitor and Respiration Pacer Regulatory Class: II (two) Product Code: 74 DPS Dated: May 12, 1998 Received: May 20, 1998
Dear Mr. Hokanson:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
1
Page 2 - Mr. D. Eugene Hokanson
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
Thomas J. Callahan
Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
FROM : D E HOKANSON INC
1 of 1 Page
к973426 510 (k) NUMBER (IF KNOWN) :
DEVICE NAME: ANS2000
INDICATIONS FOR USE:
"The ANS2000 is an ECG Monitor and Respiration Pacer that measures heart rate and provides a respiration timer for the purpose of measuring heart rate variations in response to respiration. The meaburing noard ruse in studies of patients in which it is important to know the interval between heartbeats and also to 19 important to hata analysis with the patient's breathing."
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED. }
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
(Per 21 CFR 801.109)
OR
Mark Kuan
(Division Sign-Off) (Division Sign-Olt)
Division of Cardiovascular, Respiratory,
Division of Cardiovascular, Respiratory, Division of Sical Devices
510(k) Number _
Over - The - Counter - Use (Optional Format 1-2-96)